Home / Tazemetostat / United States
US ATC L01XX72 · updated 2 Nov 2026
Tazemetostat shortage in United States
Is there a Tazemetostat shortage in United States?
Yes. As of 2 Nov 2026, 1 Tazemetostat product is reported short in United States, the first since 27 Mar 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Tazverik, Tablet, 200 mg (NDC 72607-100-00) discontinuation | Epizyme, Inc. (An Ipsen Company) | 27 Mar 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).